Matthew Sherman

Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production

Blood · 1997 · 820 citations

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma

Journal of Clinical Oncology · 2004 · Last of 12 authors · 779 citations